Neuromuscular blocking agents form a pivotal drug category in daily perioperative anaesthesia care. However, monitoring is still sub-optimally employed by anesthesiologists worldwide, with both human and logistical factors being pointed out as potential culprits.
It is important to both map the current European monitoring availability, as well as to better understand what Anesthesiologists would like to see changed and developed in the neuromuscular monitoring field.
You are therefore invited to fill in a brief 2-minute survey on the usability, availability and price sensitivity of Neuromuscular monitoring applications.
Two minutes of your time will hopefully translate into perioperative practice changes in the years to come.